As of 2025-09-04, the Fair Value of Arcturus Therapeutics Holdings Inc (ARCT) is -11.08 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 17.19 USD, the upside of Arcturus Therapeutics Holdings Inc is -164.46%.
With the market price of 17.19 USD and our fair value calculation, Arcturus Therapeutics Holdings Inc (ARCT) is not a good investment. Investing in ARCT stocks now will result in a potential loss of 164.46%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -72.10 | -203.70 | 9.30 | -29.73 | -80.94 | -75.43 |
| YoY growth | -177.31% | -182.52% | 104.57% | -419.62% | -172.30% | -169.44% |
| Market Cap (mil) | 466.71 |
| P/E | |
| Forward P/E |
| EPS | -2.22 |
| Avg earnings growth rate | -169.44% |
| TTM earnings | -60.16 |